ERBB2 and neoplasm: Based on Agilent and Illumina mRNA expression data for 86 of our tumor samples [83] (unpublished results) we were able to classify 51 of the 93 tumor samples as 16 basal-like, 15 luminal A, 9 luminal B, 5 HER2+ and 6 normal-like tumors (Additional data file 1).